NCT03975465

Brief Summary

This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on oral intake, swallowing function, and swallow-related quality of life in persons treated for cancer of the head and neck (HNCA) with radiation therapy or chemoradiotherapy (RT/CRT) at least 5 years previously.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 10, 2018

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 1, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 5, 2019

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 4, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 4, 2024

Completed
Last Updated

December 6, 2024

Status Verified

December 1, 2024

Enrollment Period

5.7 years

First QC Date

June 1, 2019

Last Update Submit

December 3, 2024

Conditions

Keywords

oropharyngeal cancerlaryngeal cancerswallowchemoradiationexpiratory muscle strength traininglong-term survivor

Outcome Measures

Primary Outcomes (7)

  • Level of Oral Intake (number)

    Change in Food Level and Drink Level on International Dysphagia Diet Standardisation Initiative (IDDSI) scale will be calculated from baseline to post-treatment. IDDSI scale rates the level of liquid or food that the person can eat. Scale values range from 0 to 7, with higher values indicating better outcome (greater ability to eat).

    8 weeks

  • Maximum Expiratory Pressure (MEP) cm H20

    Change in maximum expiratory pressure level will be calculated from baseline to post-treatment.

    8 weeks

  • Extent of hyoid movement (mm)

    From Videofluoroscopic Swallow Studies (VFSS), the change in extent of hyoid movement in mm will be determined from baseline to post-treatment.

    8 weeks

  • Upper esophageal sphincter (UES) opening width (mm)

    From Videofluoroscopic Swallow Studies (VFSS), the change in width of UES opening width in mm will be determined from baseline to post-treatment.

    8 weeks

  • Presence of pharyngeal residue (dichotomous)

    From Videofluoroscopic Swallow Studies (VFSS), the presence of residue in the pharynx (yes or no) will be determined from baseline to post-treatment.

    8 weeks

  • Penetration-Aspiration Scale rating (number)

    From Videofluoroscopic Swallow Studies (VFSS), change in the Penetration-Aspiration Scale (PAS) score will be determined from baseline to post-treatment. Penetration-Aspiration Scale is an 8-point ordinal rating scale that rates the depth to which food or liquid invades the airway. Values range from a minimum of 1 to a maximum of 8; higher values represent worse outcome (i.e. greater depth of invasion into the airway)

    8 weeks

  • Timing of Aspiration (category)

    From Videofluoroscopic Swallow Studies (VFSS), timing of aspiration will be determined from baseline to post-treatment. Timing is identified as a category, either before, during, or after.

    8 weeks

Other Outcomes (2)

  • Eating Assessment Tool (EAT-10) (number)

    8 weeks

  • M.D. Anderson Dysphagia Inventory (MDADI) (number)

    8 weeks

Study Arms (2)

Expiratory Muscle Strength Training

EXPERIMENTAL

Patients randomized to the EMST arm will use the EMST150 device as packaged, i.e. following package instructions

Behavioral: Expiratory Muscle Strength Training

Pharyngeal Muscle Strengthening Exercises

ACTIVE COMPARATOR

Patients randomized to Standard Care will receive swallowing exercises designed to strengthen muscles that contribute to pharyngeal phase motor events and increase structural range of motion

Behavioral: Pharyngeal Muscle Strengthening Exercises

Interventions

8 weeks of EMST at 75% maximum expiratory pressure (MEP)

Expiratory Muscle Strength Training

8 weeks of exercises designed to increase pharyngeal muscle strength for swallowing

Pharyngeal Muscle Strengthening Exercises

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject was treated for cancer in the oral cavity, oropharynx, hypopharynx, larynx, or for an unknown primary at least 5 years prior to enrollment. Subjects may have had surgery as long as a minimum dose of 50 Gy of radiation was part of the treatment;
  • Subject must have a current swallow complaint or impairment; these include but are not limited to reduced oral intake, perceived difficulty with bolus transport (e.g. feeling of food sticking in throat); aspiration on various bolus consistencies;
  • Ability to follow directions and engage in a program of rehabilitation

You may not qualify if:

  • the subject's swallowing problems are unrelated to treatment for HNCA (e.g. cognitive impairment, history of stroke);
  • the subject presents with contraindications for EMST as specified in the EMST150 package insert unless cleared for participation by the subject's physician. These conditions include untreated hypertension, untreated gastroesophageal reflux diseas, recent stroke, lung disease, and pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Wisconsin Milwaukee

Milwaukee, Wisconsin, 53211, United States

Location

Froedtert Hospital

Milwaukee, Wisconsin, 53226, United States

Location

MeSH Terms

Conditions

Head and Neck NeoplasmsDeglutition DisordersOropharyngeal NeoplasmsLaryngeal Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesPharyngeal NeoplasmsOtorhinolaryngologic NeoplasmsStomatognathic DiseasesLaryngeal DiseasesRespiratory Tract DiseasesRespiratory Tract Neoplasms

Study Officials

  • Barbara Pauloski, Ph.D.

    University of Wisconsin, Milwaukee

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Researchers assessing the outcomes will not know the arm to which the subject was randomized.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Subjects will be randomized to an 8-week program of either Expiratory Muscle Strength Training (EMST) or Standard Care in order to examine the impact of EMST on swallowing function
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 1, 2019

First Posted

June 5, 2019

Study Start

September 10, 2018

Primary Completion

June 4, 2024

Study Completion

June 4, 2024

Last Updated

December 6, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations